Skip to content
777 Sourcing.

Capability

pre-clinical drug discovery

Suppliers
2
States & provinces
2
Countries
1

2 pre-clinical drug discovery suppliers across 2 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

JILLION THERAPEUTICS INC.

BROOKLYN, NY

Jillion Therapeutics is a biotech company focused on CNS drug discovery, translating neuroscience into therapeutics using High-Power Screening (HPS) with DNA-Encoded Libraries (DELs) coupled with A.I. and machine learning. Its founder brings over two decades of experience from a Nobel Prize-winning lab in brain signaling and disease mechanisms. The company aims to identify novel drug candidates for neurological disorders, with potential impact on oncology and metabolic diseases.

AI and Machine LearningchemistryDNA-Encoded Library (DEL) screeningHigh-Power Screening (HPS)neuroscience

Compiled from public sources

KANNALIFE SCIENCES INC

DOYLESTOWN, PA

Kannalife Sciences, Inc., a subsidiary of Neuropathix, Inc., is a biopharmaceutical company focused on discovering, developing and commercializing breakthrough therapeutics targeting neuroinflammation, healthspan and neuropathic pain. Since 2010 it has been involved in research and development of synthetic cannabidiol (CBD) inspired therapeutics through pre-clinical drug discovery. Its lead candidate is KLS-13019, and it conducts R&D at the Pennsylvania Biotechnology Center of Bucks County in Doylestown, PA.

drug developmentmedicinal chemistryresearch and development

Compiled from public sources

Related capabilities

Other processes offered by the shops that list pre-clinical drug discovery.

Browse all capabilities